Clinical Trial Update: A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing rabeprazole and pantoprazole on stomach and esophageal acid exposure in patients with gastroesophageal reflux disease and night…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)
• Rabeprazole (rabeprazole)

Snippet

Sponsor: PriCara, Unit of Ortho-McNeil, Inc. | Conditions: Gastroesophageal Reflux | Phase 4 | Status: COMPLETED